BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang D, Xiao M, Wan ZM, Lin X, Li QY, Zheng SS. Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges. World J Gastrointest Surg 2023; 15(4): 544-552 [PMID: 37206072 DOI: 10.4240/wjgs.v15.i4.544]
URL: https://www.wjgnet.com/1007-9327/full/v15/i4/544.htm
Number Citing Articles
1
Mansour Bahardoust, Maryam Zolfaghari Dehkharghani, Pouya Ebrahimi, Maryam Najafirashed, Safa Mousavi, Meisam Haghmoradi, Mohsen Khaleghian, Adnan Tizmaghz. Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort studyBMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-02236-8
2
Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicineWorld Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424
3
Jianping Wang, Peipei Cong, Zhipeng Jin, Lingli Liu, Dongxu Sun, Wenjing Zhu, Guangjun Shi. A novel prognostic signature for hepatocellular carcinoma based on SUMOylation-related genesScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-38197-4